News
Drug Science T21 study to continue for fifth year with new partners
The new partners will help to secure the future of the project.
Search
24 results for “t21”
Industry
Grow Pharma joins T21 to help patients access more affordable medicinal cannabis
The addition of Grow Pharma allows T21 to add more cannabis-based medicines its formulary.
Industry
Khiron continues to support T21 with affordable options
Sponsored content Khiron Life Sciences is continuing to support Project T21 with affordable options, which allow for more comprehensive treatment of chronic conditions. Earlier this year Drug Science announced key […]
Insight
Medical Cannabis in Psychiatry: From Neurodiversity to Mental Health
We examine the research and real-world evidence behind the use of cannabis-based medicines in psychiatry.
Industry
Podcast | From Anecdote to Evidence: Using Data for Advanced Access with Releaf & Dr Anne Katrin Schlag
In a special edition of the Business of Cannabis Podcast, we go from anecdote to evidence with Dr Anne Katrin Schlag, Head of Research at Drug Science, and Graham Woodward, Chief Operating Officer at Releaf.
News
Closing the Gap: How Real-World Evidence Could Reshape UK Medical Cannabis Policy
UK medical cannabis clinic, Releaf, is investing in an ambitious new research programme to collect critical real-world evidence on the effects of medical cannabis treatments. Could it help bridge the […]
News
Economic analysis finds medical cannabis could save NHS £4 billion each year
The findings come from an independent economic analysis of medical cannabis for the treatment of chronic pain.
Industry
UK cannabis clinics Leva and Zerenia merge to expand patient care
The partnership aims to improve treatment options available to patients with chronic pain.
Health
Older adults report ‘considerable improvements’ with medical cannabis
A new study suggests that adults aged 65 and older experience “considerable improvements” in their health and wellbeing when prescribed cannabis-based medicines. The use of medical cannabis is said to […]
Health
Healing wounds of war: Cannabis, PTSD, and the war in Ukraine
Adam Kavalier PhD, scientific director of Anthera Pharmaceuticals, explores what we know about medical cannabis in the treatment of PTSD.
Mental health
Real-world evidence finds medical cannabis effective in PTSD and comorbid depression
PTSD symptoms significantly reduced three months after starting treatment with cannabis-based medicines.
News
UK research finds GP support for cannabis as an alternative to opioids for chronic pain
37% of GPs surveyed believe that medical cannabis has the potential to reduce patient dependency on other medications.
Industry
How allowing GPs to prescribe cannabis could ease the burden on NHS
Experts say giving GPs the right to prescribe cannabis would help drive down NHS waiting lists.
News
10 takeaways on cannabis from the UN World Drug Report
We’ve pieced together some of the key findings reflecting the use of cannabis across the globe.
News
Experts call for HHC to be regulated rather than banned
Some experts believe HHC could have ‘potential’ medicinal benefits and ‘deserves further investigation’.
Mental health
Rise in patients with ‘unmet’ mental health needs seeking medicinal cannabis
Experts report an increase in patients looking to manage anxiety and neurodevelopmental conditions, such as ADHD.
Science
UK data shows ‘considerable promise’ for medicinal cannabis in range of conditions
Prescribed cannabis was associated with an improvement in symptoms, quality of life and a reduction in opioid use.
Industry
Swiss KannaVations: how we’re closing the gender health gap
How the female-led brand is tackling the huge unmet need in women’s healthcare through research and development.
Industry
Khiron calls for wider NHS reimbursement of cannabis-based medicines following recent success
Khiron Europe is confident that its efforts in collecting evidence will allow the UK to follow in the footsteps of Germany’s thriving medical cannabis market.
Cannabis explained
The doctor’s perspective: Everything you need to know about prescribing medical cannabis
A UK cannabis prescriber shares what he has learned on his journey so far.
Case Studies
‘A second chance at life’: researchers make the case for medicinal cannabis in chronic pain
A new case study highlights the potential of cannabis for improving quality of life in patients with neuropathic pain.
Science
Cannabis improves quality of life in UK patients with chronic conditions
One in two patients were prescribed medicinal cannabis for chronic pain, with a quarter taking it to treat mental health conditions.
Science
Study: cannabis ‘effective’ in older patients with chronic conditions
Around 60% of patients with Parkinson’s disease and multiple sclerosis said cannabis was beneficial at managing their symptoms.
Mental health
How cannabis may have helped Prince Harry’s mental health – the science and expert opinion
Prince Harry comments are not only relatable to many, but are backed up by a growing body of research.